is cagrilintide a glp-1 new drug combo of semaglutide (GLP-1 receptor agonist) with (amylin analogue) failed to do as well as tirzepatide (GLP-1/GIP receptor agonist). The future of these medicines hitting different receptors Cagrilintide vs Tirzepatide Compared -

Its ability to influence various physiological functionsranging from blood pressure regulation to the modulation of pain perceptionmakes it a versatile compound for investigating systemic homeostasis in laboratory models

Wang et al, 2018

The expiration and beyond-use date (BUD) will be listed on the vial and it should not be used after that date

The study did not exclude any specific brand of drugs, but since Wegovy was only approved in Canada in November 2021, primarily for weight loss, it is likely the bulk of semaglutide users in the study were taking Ozempic, which is prescribed for diabetes

Its fair to be suspicious

A physician should also review diabetes medications, hydration status, kidney concerns, gallbladder history, gastrointestinal disease, thyroid history, current prescriptions, and long-term goals